Gabriel Leventhal, Chief Scientific Officer at Pharmabiome, spoke about NicheMap, a reference database that allows us to select the most appropriate strains to engineer targeted changes in the microbiome.
Collaborative initiatives would be needed to detect subtle associations and understand the role of the gut microbiome in the development of psychiatric symptoms over time.
The findings of a new study suggest that periodontal disease may contribute to rheumatoid arthritis by triggering specific immune responses.
Healthcare professionals area, Scientific research
Sponsored by
Download the review that summarize the scientific and clinical work conducted on the probiotic formulation Probi® Osteo.
Colette Shortt, Regulatory Specialist and Visiting Professor University of Ulster, spoke about the regulatory framework for food supplements and Live Biotherapeutic products.
Hepatic encephalopathy is a debilitating and recurring condition that causes neuropsychiatric conditions and is a common complication of cirrhosis.
The findings of a new study suggest that infants acquire their gut virome from their diet and environment rather than from their mothers.
The findings of a new study reveal a microbe-immune axis that is disrupted in pregnant animals, suggesting potential therapeutic approaches for pregnancy-associated sepsis.
Shahram Lavasani, Founder & CEO at ImmuneBiotech AB, spoke about how the research in gut-brain axes could pave the way to new microbiome based therapies in neurodegenerative diseases.
Industry
Sponsored by
Bio-Me launching an extensive qPCR solution for skin microbiome analysis.
